Related Experiment Video
Updated: Oct 3, 2025

Author Spotlight: Innovative Methods in Lymphedema and Hypertension Research
Published on: March 22, 2024
Onco-hypertension: An Emerging Specialty.
Prakash Gudsoorkar1, Rebecca Ruf2, Harsha Adnani3
1Division of Nephrology, Kidney C.A.R.E. Program, University of Cincinnati, Cincinnati, OH.
Cancer survivors are living longer but facing new cardiovascular risks, particularly hypertension. Managing high blood pressure in cancer patients requires personalized care due to complex interactions between cancer, treatments, and individual health factors.
Area of Science:
- Cardiovascular Medicine
- Oncology
Background:
- Cancer survival rates have improved due to advancements in chemotherapy, targeted therapy, and immunotherapy.
- Increased survival leads to a higher incidence of long-term cardiovascular complications in cancer patients.
- Hypertension is a significant risk factor for cardiovascular diseases and is frequently observed in cancer patients.
Purpose of the Study:
- To highlight the complex etiologies of hypertension in cancer patients.
- To emphasize the need for individualized management strategies for hypertension in this population.
- To introduce onco-hypertension as an emerging subspecialty requiring multidisciplinary collaboration.
Main Methods:
- Review of existing literature on cancer treatments and cardiovascular complications.
- Analysis of the interplay between cancer type, chemotherapeutic agents, patient demographics, and comorbidities in hypertension development.
- Discussion of current challenges and future directions in managing hypertension in cancer patients.
Main Results:
- Cancer patients present unique and multifactorial causes for hypertension.
- Current guidelines for hypertension management in cancer patients are lacking, necessitating individualized treatment plans.
- Effective management requires careful blood pressure monitoring and consideration of adjuvant therapies and cancer-related pain.
Conclusions:
- Onco-hypertension is a growing clinical area requiring a collaborative approach involving oncologists, primary care physicians, nephrologists, and cardiologists.
- Personalized hypertension management is crucial for improving cardiovascular outcomes in cancer survivors.
- Further research and guideline development are needed for the optimal care of onco-hypertension.
More Related Videos
Related Concept Videos
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

